Tick Bite Prophylaxis in Pregnancy

Prevention and Risk Assessment

The American College of Rheumatology recommends using protective clothing and tick repellents (DEET, picaridin, IR3535, oil of lemon eucalyptus, PMD, 2-undecanone, or permethrin) to prevent tick bites, as well as performing daily tick checks and promptly removing attached ticks using fine-tipped tweezers in endemic areas 1
The Infectious Diseases Society of America (IDSA) identifies high-risk tick bite criteria, including being an Ixodes species vector (blacklegged tick), occurring in highly endemic areas (parts of New England, mid-Atlantic states, Minnesota, Wisconsin), and the tick being attached for ≥36 hours (based on engorgement or known time of exposure) 1, 2

The IDSA does not recommend substituting amoxicillin for doxycycline in pregnancy due to lack of data on effective short-course regimens, need for multi-day regimen, higher risk of adverse effects, and excellent efficacy of treatment if infection develops 2, 3, 4, 5
The recommended approach is to "wait and watch" for signs and symptoms of infection for 30 days, monitoring specifically for erythema migrans (bull's-eye rash) at the bite site, and initiate prompt treatment if signs/symptoms develop 1, 2

For confirmed Lyme disease in pregnancy, amoxicillin 500 mg three times daily for 14 days is the preferred treatment, according to the IDSA 6

Clinical and epidemiological studies suggest favorable outcomes when pregnant women with Lyme disease receive standard antibiotic treatment, with little evidence supporting the existence of a congenital Lyme disease syndrome 5
The Centers for Disease Control and Prevention (CDC) recommends considering rifampin for mild cases of anaplasmosis in pregnant women, and chloramphenicol as an alternative treatment for Rocky Mountain spotted fever in pregnancy, though with higher risk of adverse outcomes 7

Unnecessary prophylactic antibiotic use in pregnancy after tick bites carries risks, including drug-associated rash, minor adverse effects, and the risk of acquiring Lyme disease being approximately the same as developing a rash from prophylactic antibiotics 5

The Centers for Disease Control and Prevention recommends rifampin as an alternative to doxycycline for mild anaplasmosis in pregnant women 8, 9
Limited case report data supports rifampin's use for mild anaplasmosis during pregnancy, with a strength of evidence based on limited data 10
For severe anaplasmosis, the benefits of doxycycline may outweigh potential risks to the fetus, according to the CDC 11
Chloramphenicol is a potential alternative for RMSF during pregnancy, but patients treated with chloramphenicol have a greater risk of death compared to those treated with doxycycline 8, 9
Caution must be used when administering chloramphenicol in the third trimester due to theoretical risk of gray baby syndrome, as noted by the CDC 10

Despite being contraindicated in pregnancy, recent systematic reviews report no evidence of teratogenicity with doxycycline use during pregnancy, according to the CDC 10, 11
Therapeutic doses of doxycycline are unlikely to pose substantial teratogenic risk, though data are insufficient to conclude no risk exists, as reported by the CDC 10, 11
For life-threatening tick-borne diseases, the benefits of doxycycline may outweigh potential risks, according to the CDC 10

Delaying treatment of severe tick-borne diseases can lead to serious complications and death, as warned by the CDC 8
Not considering disease-specific treatment alternatives, such as using chloramphenicol for anaplasmosis, which is ineffective, can be harmful, according to the CDC 8, 10
Failing to discuss potential risks versus benefits with the pregnant woman is a critical oversight, as noted by the CDC 10